[go: up one dir, main page]

KR900000321A - 19-플루오로- 또는 시아노-21-하이드록시 프로게스테론 유도체 - Google Patents

19-플루오로- 또는 시아노-21-하이드록시 프로게스테론 유도체 Download PDF

Info

Publication number
KR900000321A
KR900000321A KR1019890008781A KR890008781A KR900000321A KR 900000321 A KR900000321 A KR 900000321A KR 1019890008781 A KR1019890008781 A KR 1019890008781A KR 890008781 A KR890008781 A KR 890008781A KR 900000321 A KR900000321 A KR 900000321A
Authority
KR
South Korea
Prior art keywords
double bond
cyano
fluoro
hydrogen
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019890008781A
Other languages
English (en)
Other versions
KR0140885B1 (ko
Inventor
워위크 홀버트 진
오닐 존스톤 존
Original Assignee
개리 디. 스트리트
메렐 다우 파마슈티칼스 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 개리 디. 스트리트, 메렐 다우 파마슈티칼스 인코포레이티드 filed Critical 개리 디. 스트리트
Publication of KR900000321A publication Critical patent/KR900000321A/ko
Application granted granted Critical
Publication of KR0140885B1 publication Critical patent/KR0140885B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Insulating Materials (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)

Abstract

내용 없음

Description

19-플루오로- 또는 시아노-21-하이드록시 프로게스테론 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 일반식(I)의 화합물.
    상기식에서, R은 수소 또는이고, R2는 (H)(H), (H)(OH) 또는 O이고, R3는 디플루오로메틸, 실아노메틸 또는 시아노이고, R4는 =O, (H)(OH), (H)(OR8) 또는 =CH2이고, R5는 수소, 아미노, 하이드록시, 옥소 또는 메틸렌이고, R6는 C1내지 C6-알킬, C5내지 C7-사이클로알킬 또는 페닐이고, R8은 C2내지 C10-알카노일이며, 점선은 각각 임의의 이중결합의 존재를 의미하나, 단 5,6-(이중결합)은 R4가 (H)(OH)이거나 4,5-위치 또는 6,7-위치에 이중결합이 존재하지 않는 경우에만 존재하며, 9,11-(이중결합)은 R2가 (H)(H)인 경우에만 존재할 수 있다.
  2. 제1항에 있어서, 일반식(I′)의 구조를 갖는 화합물.
    상기식에서, R은 수소 또는이고, R2는 (H)(H), (H)(OH) 또는 O이고, R3는 디플루오로메틸이고, R4는 =O, (H)(OH), 또는 =CH2이고, R6는 C1내지 C6-알킬, C5내지 C7-사이클로알킬 또는 페닐이고, 점선은 각각 임의의 이중결합의 존재를 의미하나, 단, 5,6-(이중결합)은 R4가 (H)(OH)이거나 4,5-위치에 이중결합이 존재하지 않는 경우에만 존재한다.
  3. 제1항에 있어서, 19,19-디플루오로-21-하이드록시 프레그느-4-엔-3,20-디온인 화합물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890008781A 1988-06-28 1989-06-26 19-플루오로 또는 시아노-21-하이드록시 프로게스테론 유도체 Expired - Fee Related KR0140885B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US212,410 1988-06-28
US07/212,410 US4920114A (en) 1988-06-28 1988-06-28 19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as 19-hydroxylase inhibitors

Publications (2)

Publication Number Publication Date
KR900000321A true KR900000321A (ko) 1990-01-30
KR0140885B1 KR0140885B1 (ko) 1998-06-15

Family

ID=22790899

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890008781A Expired - Fee Related KR0140885B1 (ko) 1988-06-28 1989-06-26 19-플루오로 또는 시아노-21-하이드록시 프로게스테론 유도체

Country Status (19)

Country Link
US (1) US4920114A (ko)
EP (1) EP0348911B1 (ko)
JP (1) JP2727466B2 (ko)
KR (1) KR0140885B1 (ko)
CN (1) CN1039424A (ko)
AT (1) ATE100462T1 (ko)
AU (1) AU610413B2 (ko)
CA (1) CA1321579C (ko)
DE (1) DE68912422T2 (ko)
DK (1) DK318489A (ko)
ES (1) ES2061802T3 (ko)
FI (1) FI893162L (ko)
HU (1) HUT51289A (ko)
IL (1) IL90728A0 (ko)
NO (1) NO892679L (ko)
NZ (1) NZ229694A (ko)
PH (1) PH25771A (ko)
PT (1) PT90989B (ko)
ZA (1) ZA894753B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124574A (en) * 1964-03-10 Iz-halo pregnenes
US3154569A (en) * 1961-10-10 1964-10-27 Vismara Francesco Spa 19-nitrilosteroids and process for producing 19-norsteroids
IT1051705B (it) * 1962-05-12 1981-05-20 Vismara Spa F Metodo per la preparazione di intermedi steroidali
GB984093A (en) * 1962-02-19 1965-02-24 Syntex Corp Improvements in or relating to 19-halo-pregnane compounds
US3257389A (en) * 1962-09-21 1966-06-21 Syntex Corp 19-bisdifluoro-pregnanes
US3257435A (en) * 1962-09-21 1966-06-21 Syntex Corp 19-bisdifluoro pregnanes
US3205228A (en) * 1963-03-01 1965-09-07 Syntex Corp 19-substituted pregnenes
US3159620A (en) * 1963-05-22 1964-12-01 Vismara Francesco Spa Process for the preparation of 17 alpha-ethynyl-19-norandrostene compounds
US3394128A (en) * 1964-09-26 1968-07-23 Syntex Corp 19-halo-androstane and pregnane derivatives and processes for the preparation thereof
FR2462445A1 (fr) * 1979-07-31 1981-02-13 Roussel Uclaf Nouveaux derives 17-/(hydroxymethyl) (formamido) methylene/steroides, leur procede de preparation et leur application a l'introduction de la chaine laterale hydroxyacetyle
US4293548A (en) * 1980-09-02 1981-10-06 Merrell Dow Pharmaceuticals Inc. 18-Substituted pregn-4-ene-3,20-diones

Also Published As

Publication number Publication date
DK318489A (da) 1989-12-29
ZA894753B (en) 1990-03-28
AU610413B2 (en) 1991-05-16
NZ229694A (en) 1992-03-26
DK318489D0 (da) 1989-06-27
ATE100462T1 (de) 1994-02-15
ES2061802T3 (es) 1994-12-16
US4920114A (en) 1990-04-24
PT90989B (pt) 1994-11-30
CN1039424A (zh) 1990-02-07
JP2727466B2 (ja) 1998-03-11
JPH0248597A (ja) 1990-02-19
IL90728A0 (en) 1990-01-18
NO892679D0 (no) 1989-06-27
KR0140885B1 (ko) 1998-06-15
EP0348911A3 (en) 1990-03-28
FI893162L (fi) 1989-12-29
CA1321579C (en) 1993-08-24
HUT51289A (en) 1990-04-28
EP0348911B1 (en) 1994-01-19
EP0348911A2 (en) 1990-01-03
PT90989A (pt) 1989-12-29
AU3712689A (en) 1990-01-04
DE68912422D1 (de) 1994-03-03
NO892679L (no) 1989-12-29
PH25771A (en) 1991-10-18
DE68912422T2 (de) 1994-08-18
FI893162A0 (fi) 1989-06-28

Similar Documents

Publication Publication Date Title
KR920021506A (ko) 19-노르 비타민 d 화합물 합성용 중간체
TR200202287T2 (tr) Sübstitüe edilmiş N6 heterosiklik adenosin türevleri
KR920003968A (ko) 염증성 장 질환의 치료방법
ATE128983T1 (de) 17-spirofuran-3'-yliden steroide.
KR890006667A (ko) 안드로스탄 17-카복실산 에스테르, 이의 제조방법, 및 이를 함유하는 약제
KR950000663A (ko) 트리테르펜 유도체 및 이를 함유하는 엔도텔린-수용체 길항물질
KR920701217A (ko) 리피드 a 단당류 녹체
FI944086A0 (fi) Antiparasiittiset avermektiini- ja milbemysiinijohdannaiset
KR880001693A (ko) 신규의 18- 페닐오 에스트란 유도체
KR900000321A (ko) 19-플루오로- 또는 시아노-21-하이드록시 프로게스테론 유도체
ZA899670B (en) Phosphonic acid substituted steroids as steroid 5-alpha-reductase inhibitors
KR890007738A (ko) 파킨슨씨병 치료용 에르골린 유도체
KR900000335A (ko) 히드록시알킬시스테인 유도체 및 이를 함유하는 거담제
KR890014107A (ko) 백금 화학 요법약제
KR920016089A (ko) 제i형 당뇨병의 치료방법
Ely et al. Δ1-Hydrocortisone: Plasma 17-Hydroxycorticosteroid Concentrations Following Oral and IV Administration.
KR940021064A (ko) 프레그네인 유도체의 사용 방법
KR890003752A (ko) 2-피리미디닐-피페라딘 유도체의 용도
IT1154735B (it) Derivati d'amino-14 steroidi e procedimento per la loro preparazione
BR0014687A (pt) Compostos de taxano pentacìclico
KR920702685A (ko) 4,6-o- 히드록시포스포릴글루코사민 유도체
KR890012949A (ko) O-아실아미드옥심 유도체
CA2086919A1 (en) Process for the production of unsaturated 17.alpha.-cyanomethyl -17.beta. hydroxy steroids
ATE154606T1 (de) 2beta,19-methylenamin überbrückte steroide als aromatasehemmer
KR910000777A (ko) 정균 활성을 갖는 안트라사이클린 유도체

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19890626

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19940622

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19890626

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19971010

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19980112

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19980316

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19980316

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20010314

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20020313

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20030312

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20030312

Start annual number: 6

End annual number: 6

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

Termination category: Default of registration fee

Termination date: 20050111